Long-term risk of BP values above normal for cardiovascular mortality: a 24-year observation of Japanese aged 30 to 92 years. J Hypertens. 2012;30:2299 306. S8.1.1-8. Murakami Y. Meta-analyses using individual participant data from cardiovascular cohort studies in Japan: current status and future directions. J Epidemiol. 2014;24:96 101. S8.1.1-9. van Dieren S, Kengne AP, Chalmers J, et al. Effects of blood pres- sure lowering on cardiovascular outcomes in different cardiovascu- lar risk groups among participants with type 2 diabetes. Diabetes Res Clin Pract. 2012;98:83 90. S8.1.1-10. Sundstrom J, Arima H, Woodward M, et al. Blood Pressure Lowering Treatment Trialists' Collaboration. Blood pressure-low- ering treatment based on cardiovascular risk: a meta-analysis of individual patient data. Lancet. 2014;384:591 8. S8.1.1-11. Turnbull F, Neal B, Algert C, et al. Effects of different blood pressure-lowering regimens on major cardiovascular events in individuals with and without diabetes mellitus: results of prospec- tively designed overviews of randomized trials. Arch Intern Med. 2005;165:1410 9. S8.1.1-12. Wang J-G, Staessen JA, Franklin SS, et al. Systolic and diastolic blood pressure lowering as determinants of cardiovascular out- come. Hypertension. 2005;45:907 13. S8.1.1-13. Turnbull F, Woodward M, Neal B, et al. Do men and women respond differently to blood pressure-lowering treatment? Results of prospectively designed overviews of randomized trials. Eur Heart J. 2008;29:2669 80. S8.1.1-14. Turnbull F, Neal B, Ninomiya T, et al. Effects of different regi- mens to lower blood pressure on major cardiovascular events in older and younger adults: meta-analysis of randomised trials. BMJ. 2008;336:1121 3. S8.1.1-15. Du X, Ninomiya T, de Galan B, et al. Risks of cardiovascular events and effects of routine blood pressure lowering among patients with type 2 diabetes and atrial fibrillation: results of the ADVANCE study. Eur Heart J. 2009;30:1128 35. S8.1.1-16. Czernichow S, Ninomiya T, Huxley R, et al. 